Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram and Tianeptine in Autism Spectrum Disorder
NCT04145076Unknown
- Sponsor
- King's College London
- Start
- Dec 2014
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of citalopram and tianeptine in major depressive disorder (MDD) and anxiety disorder (6 arms), sponsored by King's College London. Primary endpoints: Brain excitation and inhibition response to pharmacological stimulation, Brain activation response to pharmacological stimulation and 1 more. Status: unknown.
02
Drugs
citalopramtianeptine
03
Conditions
major depressive disorder (MDD)anxiety disorder
Beyond the preview
Go deeper on NCT04145076.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04145076.